Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Pacira BioSciences, Inc.Bullish
DOMA Perpetual Capital Management and associated investors sold a total of 2,936,794 shares of Pacira BioSciences in open-market transactions on October 8 and October 13, 2026. This filing confirms a significant reduction in the reporting persons' equity stake in the company.…more
Pacira BioSciences, Inc.
Insider Lauren Riker of Pacira BioSciences reported a change in beneficial ownership of securities as of October 8, 2026. This filing is a Form 4 submission detailing the insider's equity transaction.…more
Pacira BioSciences, Inc.
Viatris Inc. has entered into an agreement on October 8, 2026, to acquire Pacira BioSciences, Inc. Viatris plans to commence a tender offer to acquire all outstanding shares of Pacira, followed by a merger. This filing serves as a pre-commencement communication, and the specific terms of the tender offer will be detailed in a future Schedule TO filing.…more
18 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
PharmaCorp to Present at Planet MicroCap Toronto 2026 Conference
PharmaCorp announced that its senior management will present at the Planet MicroCap Toronto 2026 Conference on October 28. The event will provide an opportunity for management to engage with investors and discuss the company's business strategy.…more
●●●●●●●● ●●●●● ●●●●●●
PharmaCorp announced the appointment of Andrew Hodson as its new Chief Financial Officer, effective October 27, 2026. This leadership change is intended to support the company's ongoing strategy of acquiring and integrating pharmacies across Canada.…more
●●●●●●●● ●●●●● ●●●●●●
The Nasdaq Composite fell over 300 points as rising oil prices and geopolitical tensions weakened investor sentiment. The CNN Fear & Greed Index remains in the 'Fear' zone, reflecting ongoing market uncertainty.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.